SWK (NASDAQ:SWKH - Get Free Report) is expected to issue its Q2 2025 quarterly earnings data after the market closes on Thursday, August 14th. Analysts expect the company to announce earnings of $0.18 per share for the quarter.
SWK (NASDAQ:SWKH - Get Free Report) last posted its earnings results on Thursday, May 15th. The company reported $0.66 earnings per share for the quarter, topping analysts' consensus estimates of $0.29 by $0.37. The business had revenue of $11.83 million for the quarter. SWK had a return on equity of 8.58% and a net margin of 39.60%.
SWK Stock Performance
Shares of SWKH stock traded up $0.18 during trading on Friday, reaching $14.73. 14,366 shares of the company's stock were exchanged, compared to its average volume of 12,604. The company has a quick ratio of 11.30, a current ratio of 11.30 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $180.74 million, a PE ratio of 9.95 and a beta of 0.16. SWK has a twelve month low of $13.17 and a twelve month high of $20.49. The firm's fifty day moving average price is $14.82 and its 200-day moving average price is $15.66.
Analyst Upgrades and Downgrades
SWKH has been the topic of a number of recent analyst reports. Wall Street Zen lowered SWK from a "buy" rating to a "hold" rating in a report on Thursday, May 22nd. Maxim Group reduced their price target on SWK from $21.00 to $18.00 and set a "buy" rating for the company in a research note on Monday, May 19th.
Read Our Latest Stock Report on SWK
Institutional Trading of SWK
An institutional investor recently raised its position in SWK stock. Empowered Funds LLC boosted its position in SWK Holdings Corp. (NASDAQ:SWKH - Free Report) by 3.7% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 53,809 shares of the company's stock after purchasing an additional 1,929 shares during the quarter. Empowered Funds LLC owned about 0.44% of SWK worth $936,000 at the end of the most recent reporting period. Institutional investors own 99.27% of the company's stock.
SWK Company Profile
(
Get Free Report)
SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.
See Also

Before you consider SWK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SWK wasn't on the list.
While SWK currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.